KRTX
Karuna Therapeutics, Inc.
Director Atul Pande sold $466K of Karuna Therapeutics, Inc.
Sold$466,350
$93.27Price
5,000Shares
−100%Stake
What KRTX did after the filing
Prices for KRTX after this filing aren't in yet.
Traded Fri, Jun 12. Filed Mon, Jun 15, 5:19 PM ET, after the close. Not investment advice.